SA
AFMBX logo
American Funds American Balanced Fund(AFMBX)
Last print 17 weeks agoAbout this dataData status
$38.84▼-0.47 (-1.20%)Stale · 17 weeks old

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

American Balanced Fund F-3 (AFMBX)

Book Value Per Share

0.09

TTM · Retrieved:

AFMBX logo

AFMBX Book Value Per Share

Current (TTM)0.09
AFMBX Book Value per Share (0.04 → 0.09)
High-resolution chart · PNG

What is book value per share?

Total equity divided by shares outstanding.

Compare book value per share

AFMBX book value per share history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.

American Balanced Fund F-3 Book Value Per Share — Annual fiscal periods
Period endingBook Value Per ShareChange
0.0873+14.99%
0.0759+4.81%
0.0724+11.52%
0.0649−3.62%
0.0674−0.17%
0.0675−0.57%
0.0679+5.91%
0.0641+9.23%
0.0587−9.68%
0.065+40.75%
0.0462+13.30%
0.0407—

Frequently asked questions: AFMBX book value per share

What is American Balanced Fund F-3 (AFMBX)'s current book value per share?

American Balanced Fund F-3 (AFMBX)'s latest reported book value per share (TTM) is 0.09 as of Nov 21, 2026. Total equity divided by shares outstanding.

How much historical book value per share data is available for AFMBX?

Stock Alarm Pro provides 12 dated annual fiscal periods observations for American Balanced Fund F-3 (AFMBX)'s book value per share, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare AFMBX's book value per share to peers or set an alert?

You can compare AFMBX's book value per share directly against sector peers (JPM, V, MA, BAC) on Stock Alarm Pro, open the multi-ticker series in Chart Studio, or set real-time price and valuation alerts on AFMBX delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.